Skip to main content

Thank you for visiting nature.com. You are using a browser version with limited support for CSS. To obtain the best experience, we recommend you use a more up to date browser (or turn off compatibility mode in Internet Explorer). In the meantime, to ensure continued support, we are displaying the site without styles and JavaScript.

  • Review
  • Published:

Hematopoietic SCT with cryopreserved grafts: adverse reactions after transplantation and cryoprotectant removal before infusion

Bone Marrow Transplantation volume 49, pages 469–476 (2014)Cite this article

Subjects

Abstract

Transplantation of hematopoietic stem cells (HSCs) has been successfully developed as a part of treatment protocols for a large number of clinical indications, and cryopreservation of both autologous and allogeneic sources of HSC grafts is increasingly being used to facilitate logistical challenges in coordinating the collection, processing, preparation, quality control testing and release of the final HSC product with delivery to the patient. Direct infusion of cryopreserved cell products into patients has been associated with the development of adverse reactions, ranging from relatively mild symptoms to much more serious, life-threatening complications, including allergic/gastrointestinal/cardiovascular/neurological complications, renal/hepatic dysfunctions, and so on. In many cases, the cryoprotective agent (CPA) used—which is typically dimethyl sulfoxide (DMSO)—is believed to be the main causal agent of these adverse reactions and thus many studies recommend depletion of DMSO before cell infusion. In this paper, we will briefly review the history of HSC cryopreservation, the side effects reported after transplantation, along with advances in strategies for reducing the adverse reactions, including methods and devices for removal of DMSO. Strategies to minimize adverse effects include medication before and after transplantation, optimizing the infusion procedure, reducing the DMSO concentration or using alternative CPAs for cryopreservation and removing DMSO before infusion. For DMSO removal, besides the traditional and widely applied method of centrifugation, new approaches have been explored in the past decade, such as filtration by spinning membrane, stepwise dilution-centrifugation using rotating syringe, diffusion-based DMSO extraction in microfluidic channels, dialysis and dilution-filtration through hollow-fiber dialyzers and some instruments (CytoMate, Sepax S-100, Cobe 2991, microfluidic channels, dilution-filtration system, etc.) as well. However, challenges still remain: development of the optimal (fast, safe, simple, automated, controllable, effective and low cost) methods and devices for CPA removal with minimum cell loss and damage remains an unfilled need.

This is a preview of subscription content, access via your institution

Access options

Buy this article

  • Purchase on Springer Link
  • Instant access to full article PDF
Buy now

Prices may be subject to local taxes which are calculated during checkout

Similar content being viewed by others

References

  1. Thomas ED, Lochte HL, Lu WC, Ferrebee JW . Intravenous infusion of bone marrow in patients receiving radiation and chemotherapy. N Engl J Med 1957; 257: 491–496.

    Article  CAS  PubMed  Google Scholar 

  2. Akkök ÇA, Holte MR, Tangen JM, Østenstad B, Bruserud Ø . Hematopoietic engraftment of dimethyl sulfoxide-depleted autologous peripheral blood progenitor cells. Transfusion 2009; 49: 354–361.

    PubMed  Google Scholar 

  3. Bakken AM, Bruserud O, Abrahamsen JF . No differences in colony formation of peripheral blood stem cells frozen with 5% or 10% dimethyl sulfoxide. J Hematother Stem Cell Resh 2003; 12: 351–358.

    CAS  Google Scholar 

  4. Cordoba R, Arrieta R, Kerguelen A, Hernandez-Navarro F . The occurrence of adverse events during the infusion of autologous peripheral blood stem cells is related to the number of granulocytes in the leukapheresis product. Bone Marrow Transplant 2007; 40: 1063–1067.

    CAS  PubMed  Google Scholar 

  5. Foïs E, Desmartin M, Benhamida S, Xavier F, Vanneaux V, Rea D et al. Recovery, viability and clinical toxicity of thawed and washed haematopoietic progenitor cells: analysis of 952 autologous peripheral blood stem cell transplantations. Bone Marrow Transplant 2007; 40: 831–835.

    PubMed  Google Scholar 

  6. Hidalgo J, Krone R, Rich M, Blum K, Adkins D, Fan M et al. Supraventricular tachyarrhythmias after hematopoietic stem cell transplantation: incidence, risk factors and outcomes. Bone Marrow Transplant 2004; 34: 615–619.

    CAS  PubMed  Google Scholar 

  7. Hirata Y, Kishino K, Onozaki F, Nakaki Y, Yamamoto C, Matsuyama T et al. Use of cryoprotectant-depleted allogeneic peripheral blood stem cells for transplantation. Hematol 2011; 16: 221–224.

    CAS  Google Scholar 

  8. Donmez A, Tombuloglu M, Gungor A, Soyer N, Saydam G, Cagirgan S . Clinical side effects during peripheral blood progenitor cell infusion. Transfus Apher Sci 2007; 36: 95–101.

    PubMed  Google Scholar 

  9. Otrock ZK, Beydoun A, Barada WM, Masroujeh R, Bazarbachi A, Hourani R . Transient global amnesia associated with the infusion of DMSO-cryopreserved autologous peripheral blood stem cells. Haematol Haematol 2008; 93: e36–e37.

    Google Scholar 

  10. Junior AM, Arrais CA, Saboya R, Velasques RD, Junqueira PL, Dulley FL . Neurotoxicity associated with dimethylsulfoxide-preserved hematopoietic progenitor cell infusion. Bone Marrow Transplant 2008; 41: 95–96.

    CAS  PubMed  Google Scholar 

  11. Hentschke S, Hentschke M, Hummel K, Salwender HJ, Braumann D, Stang A . Bilateral thalamic infarction after reinfusion of DMSO-preserved autologous stem cells. Leuk Lymphoma 2006; 47: 2418–2420.

    PubMed  Google Scholar 

  12. Mueller LP, Theurich S, Christopeit M, Grothe W, Muetherig A, Weber T et al. Neurotoxicity upon infusion of dimethylsulfoxide-cryopreserved peripheral blood stem cells in patients with and without pre-existing cerebral disease. Eur J Haematol 2007; 78: 527–531.

    CAS  PubMed  Google Scholar 

  13. Calmels B, Houze P, Hengesse J, Ducrot T, Malenfant C, Chabannon C . Preclinical evaluation of an automated closed fluid management device: Cytomate, for washing out DMSO from hematopoietic stem cell grafts after thawing. Bone Marrow Transplant 2003; 31: 823–828.

    CAS  PubMed  Google Scholar 

  14. Kersting S, Verdonck LF . Stem cell transplantation nephropathy: a report of six cases. Biol Blood Marrow Transplant 2007; 13: 638–643.

    PubMed  Google Scholar 

  15. Konuma T, Ooi J, Takahashi S, Tomonari A, Tsukada N, Kobayashi T et al. Cardiovascular toxicity of cryopreserved cord blood cell infusion. Bone Marrow Transplant 2008; 41: 861–865.

    CAS  PubMed  Google Scholar 

  16. Petropoulou AD, Bellochine R, Norol F, Marie J, Rio B . Coronary artery spasm after infusion of cryopreserved cord blood cells. Bone Marrow Transplant 2007; 40: 397–398.

    CAS  PubMed  Google Scholar 

  17. Sahin F, Turk UO, Yargucu F, Donmez A, Cagirgan S . Hypothermia during the infusion of cryopreserved autologous peripheral stem cell causes electrocardiographical changes: report of two cases. Am J Hematol 2006; 81: 627–630.

    PubMed  Google Scholar 

  18. Ruiz-Delgado GJ, Mancías-Guerra C, Tamez-Gómez EL, Rodríguez-Romo LN, López-Otero A, Hernández-Arizpe A et al. Dimethyl sulfoxide-induced toxicity in cord blood stem cell transplantation: report of three cases and review of the literature. Acta Haematol 2009; 122: 1–5.

    PubMed  Google Scholar 

  19. Schlegel PG, Wölfl M, Schick J, Winkler B, Eyrich M . Transient loss of consciousness in pediatric recipients of dimethylsulfoxide (DMSO)-cryopreserved peripheral blood stem cells independent of morphine co-medication. Haematologica 2009; 94: 1473–1475.

    PubMed  PubMed Central  Google Scholar 

  20. Zenhäusern R, Tobler A, Leoncini L, Hess OM, Ferrari P . Fatal cardiac arrhythmia after infusion of dimethyl sulfoxide-cryopreserved hematopoietic stem cells in a patient with severe primary cardiac amyloidosis and end-stage renal failure. Ann Hematol 2000; 79: 523–526.

    PubMed  Google Scholar 

  21. Huang S, Law P, Young D, Ho AD . Candidate hematopoietic stem cells from fetal tissues, umbilical cord blood vs adult bone marrow and mobilized peripheral blood. Exp Hematol 1998; 26: 1162–1171.

    CAS  PubMed  Google Scholar 

  22. Tian X, Kaufman DS . Hematopoietic development of human embryonic stem cells in culture. Methods Mol Biol 2008; 430: 119–133.

    CAS  PubMed  Google Scholar 

  23. BARNES D, LOUTIT J . The radiation recovery factor—preservation by the Polge–Smith–Parkes technique. J Natl Cancer Inst 1955; 15: 901–905.

    CAS  PubMed  Google Scholar 

  24. Berz D, McCormack EM, Winer ES, Colvin GA, Quesenberry PJ . Cryopreservation of hematopoietic stem cells. Am J Hematol 2007; 82: 463–472.

    PubMed  PubMed Central  Google Scholar 

  25. Fleming KK, Hubel A . Cryopreservation of hematopoietic and non-hematopoietic stem cells. Transfus Apher Sci 2006; 34: 309–315.

    CAS  PubMed  Google Scholar 

  26. Sputtek A, Sputtek R . Cryopreservation in transfusion medicine and hematology. In: Fuller B, Lane N, Benson E (eds). Life in the Frozen State. CRC Press: Boca Raton, FL, USA, 2004 pp 483–504.

    Google Scholar 

  27. Woods EJ, Pollok KE, Byers MA, Perry BC, Purtteman J, Heimfeld S et al. Cord blood stem cell cryopreservation. Transfus Med Hemother 2007; 34: 276–285.

    Google Scholar 

  28. Hunt CJ . Cryopreservation of human stem cells for clinical application: a review. Transf Med Hemother 2011; 38: 107–123.

    Google Scholar 

  29. Kuwano K, Aruga Y, Saga N . Cryopreservation of the conchocelis of Porphyra (Rhodophyta) by applying a simple prefreezing system. J Phycol 1994; 30: 566–570.

    Google Scholar 

  30. Shu ZQ, Kang XJ, Chen HH, Zhou XM, Purtteman J, Yadock D et al. Development of a reliable low-cost controlled cooling rate instrument for the cryopreservation of hematopoietic stem cells. Cytotherapy 2010; 12: 161–169.

    CAS  PubMed  PubMed Central  Google Scholar 

  31. Alessandrino P, Bernasconi P, Caldera D, Colombo A, Bonfichi M, Malcovati L et al. Adverse events occurring during bone marrow or peripheral blood progenitor cell infusion: analysis of 126 cases. Bone Marrow Transplant 1999; 23: 533–537.

    CAS  PubMed  Google Scholar 

  32. Bauwens D, Hantson P, Laterre P, Michaux L, Latinne D, De Tourtchaninoff M et al. Recurrent seizure and sustained encephalopathy associated with dimethylsulfoxide-preserved stem cell infusion. Leuk Lymphoma 2005; 46: 1671–1674.

    CAS  PubMed  Google Scholar 

  33. Benekli M, Anderson B, Wentling D, Bernstein S, Czuczman M, McCarthy P . Severe respiratory depression after dimethylsulphoxide-containing autologous stem cell infusion in a patient with AL amyloidosis. Bone Marrow Transplant 2000; 25: 1299–1301.

    CAS  PubMed  Google Scholar 

  34. Bojanic I, Cepulic BG, Mazic S, Batinic D, Nemet D, Labar B . Toxicity related to autologous peripheral blood haematopoietic progenitor cell infusion is associated with number of granulocytes in graft, gender and diagnosis of multiple myeloma. Vox Sang 2008; 95: 70–75.

    CAS  PubMed  Google Scholar 

  35. Davis JM, Rowley SD, Braine HG, Piantadosi S, Santos GW . Clinical toxicity of cryopreserved bone marrow graft infusion. Blood 1990; 75: 781–786.

    CAS  PubMed  Google Scholar 

  36. Hoyt R, Szer J, Grigg A . Neurological events associated with the infusion of cryopreserved bone marrow and/or peripheral blood progenitor cells. Bone Marrow Transplant 2000; 25: 1285–1287.

    CAS  PubMed  Google Scholar 

  37. Milone G, Mercurio S, Strano A, Leotta S, Pinto V, Battiato K et al. Adverse events after infusions of cryopreserved hematopoietic stem cells depend on non-mononuclear cells in the infused suspension and patient age. Cytotherapy 2007; 9: 348–355.

    CAS  PubMed  Google Scholar 

  38. Rapoport AP, Rowe JM, Packman CH, Ginsberg SJ . Cardiac arrest after autologous marrow infusion. Bone Marrow Transplant 1991; 7: 401–403.

    CAS  PubMed  Google Scholar 

  39. Rowley SD, Feng Z, Yadock D, Holmberg L, MacLeod B, Heimfeld S . Post-thaw removal of DMSO does not completely abrogate infusional toxicity or the need for pre-infusion histamine blockade. Cytotherapy 1999; 1: 439–446.

    CAS  PubMed  Google Scholar 

  40. Rowley S, MacLeod B, Heimfeld S, Holmberg L, Besinger W . Severe central nervous system toxicity associated with the infusion of cryopreserved PBSC components. Cytotherapy 1999; 1: 311–317.

    CAS  PubMed  Google Scholar 

  41. Smith DM, Weisenburger DD, Bierman P, Kessinger A, Vaughan WP, Armitage JO . Acute renal failure associated with autologous bone marrow transplantation. Bone Marrow Transplant 1987; 2: 195–201.

    CAS  PubMed  Google Scholar 

  42. Stroncek D, Fautsch S, Lasky L, Hurd D, Ramsay N, McCullough J . Adverse reactions in patients transfused with cryopreserved marrow. Transfusion 1991; 31: 521–526.

    CAS  PubMed  Google Scholar 

  43. Windrum P, Morris TCM . Severe neurotoxicity because of dimethyl sulphoxide following peripheral blood stem cell transplantation. Bone Marrow Transplant 2003; 31: 315.

    CAS  PubMed  Google Scholar 

  44. Zambelli A, Poggi G, Da Prada G, Pedrazzoli P, Cuomo A, Miotti D et al. Clinical toxicity of cryopreserved circulating progenitor cells infusion. Anticancer Res 1998; 18: 4705–4708.

    CAS  PubMed  Google Scholar 

  45. Calmels B, Lemarié C, Esterni B, Malugani C, Charbonnier A, Coso D et al. Occurrence and severity of adverse events after autologous hematopoietic progenitor cell infusion are related to the amount of granulocytes in the apheresis product. Transfusion 2007; 47: 1268–1275.

    PubMed  Google Scholar 

  46. Oziel-Taieb S, Faucher-Barbey C, Chabannon C, Ladaique P, Saux P, Gouin F et al. Early and fatal immune haemolysis after so-called ‘minor’ ABO-incompatible peripheral blood stem cell allotransplantation. Bone Marrow Transplant 1997; 19: 1155–1156.

    CAS  PubMed  Google Scholar 

  47. Salmon JP, Michaux S, Hermanne JP, Baudoux E, Gérard C, Sontag-Thull D et al. Delayed massive immune hemolysis mediated by minor ABO incompatibility after allogeneic peripheral blood progenitor cell transplantation. Transfusion 1999; 39: 824–827.

    CAS  PubMed  Google Scholar 

  48. Sauer-Heilborn A, Kadidlo D, McCullough J . Patient care during infusion of hematopoietic progenitor cells. Transfusion 2004; 44: 907–916.

    PubMed  Google Scholar 

  49. Schwella N, Zimmermann R, Heuft HG, Blasczyk R, Beyer J, Rick O et al. Microbiologic contamination of peripheral blood stem cell autografts. Vox Sang 1994; 67: 32–35.

    CAS  PubMed  Google Scholar 

  50. Decot V, Houze P, Stoltz J-, Bensoussan D . Quantification of residual dimethylsulfoxide after washing cryopreserved stem cells and thawing tissue grafts. Biomed Mater Eng 2009; 19: 293–300.

    CAS  PubMed  Google Scholar 

  51. Laroche V, McKenna DH, Moroff G, Schierman T, Kadidlo D, McCullough J . Cell loss and recovery in umbilical cord blood processing: a comparison of postthaw and postwash samples. Transfusion 2005; 45: 1909–1916.

    PubMed  Google Scholar 

  52. Lemarie C, Calmels B, Malenfant C, Arneodo V, Blaise D, Viret F et al. Clinical experience with the delivery of thawed and washed autologous blood cells, with an automated closed fluid management device: CytoMate. Transfusion 2005; 45: 737–742.

    PubMed  Google Scholar 

  53. Nagamura-Inoue T, Shioya M, Sugo M, Cui Y, Takahashi A, Tomita S et al. Wash-out of DMSO does not improve the speed of engraftment of cord blood transplantation: follow-up of 46 adult patients with units shipped from a single cord blood bank. Transfusion 2003; 43: 1285–1295.

    PubMed  Google Scholar 

  54. Perotti CG, Fante CD, Viarengo G, Papa P, Rocchi L, Bergamaschi P et al. A new automated cell washer device for thawed cord blood units. Transfusion 2004; 44: 900–906.

    PubMed  Google Scholar 

  55. Rodríguez L, Velasco B, García J, Martín-Henao GÁ . Evaluation of an automated cell processing device to reduce the dimethyl sulfoxide from hematopoietic grafts after thawing. Transfusion 2005; 45: 1391–1397.

    PubMed  Google Scholar 

  56. Rodriguez L, Azqueta C, Azzalin S, Garcia J, Querol S . Washing of cord blood grafts after thawing: high cell recovery using an automated and closed system. Vox Sang 2004; 87: 165–172.

    CAS  PubMed  Google Scholar 

  57. Rubinstein P, Dobrila L, Rosenfield R, Adamson J, Migliaccio G, Migliaccio A et al. Processing and cryopreservation of placental umbilical-cord blood for unrelated bone-marrow reconstitution. Proc Natl Acad Sci USA 1995; 92: 10119–10122.

    CAS  PubMed  PubMed Central  Google Scholar 

  58. Scerpa MC, Daniele N, Landi F, Ciammetti C, Rossi C, Isacchi G et al. Automated washing of human progenitor cells: evaluation of apoptosis and cell necrosis. Transfus Med 2011; 21: 402–407.

    CAS  PubMed  Google Scholar 

  59. Syme R, Bewick M, Stewart D, Porter K, Chadderton T, Glück S . The role of depletion of dimethyl sulfoxide before autografting: on hematologic recovery, side effects, and toxicity. Biol Blood Marrow Transplant 2004; 10: 135–141.

    CAS  PubMed  Google Scholar 

  60. Rubinstein P, Carrier C, Scaradavou A, Kurtzberg J, Adamson J, Migliaccio A et al. Outcomes among 562 recipients of placental-blood transplants from unrelated donors. N Engl J Med 1998; 339: 1565–1577.

    CAS  PubMed  Google Scholar 

  61. Ferrucci PF, Martinoni A, Cocorocchio E, Civelli M, Cinieri S, Cardinale D et al. Evaluation of acute toxicities associated with autologous peripheral blood progenitor cell reinfusion in patients undergoing high-dose chemotherapy. Bone Marrow Transplant 2000; 25: 173–177.

    CAS  PubMed  Google Scholar 

  62. Lovelock JE, Bishop MW . Prevention of freezing damage to living cells by dimethyl sulphoxide. Nature 1959; 183: 1394–1395.

    CAS  PubMed  Google Scholar 

  63. Santos NC, Figueira-Coelho J, Martins-Silva J, Saldanha C . Multidisciplinary utilization of dimethyl sulfoxide: pharmacological, cellular, and molecular aspects. Biochem Pharmacol 2003; 65: 1035–1041.

    CAS  PubMed  Google Scholar 

  64. Cavas M, Beltrán D, Navarro JF . Behavioural effects of dimethyl sulfoxide (DMSO): changes in sleep architecture in rats. Toxicol Lett 2005; 157: 221–232.

    CAS  PubMed  Google Scholar 

  65. Qi W, Ding D, Salvi RJ . Cytotoxic effects of dimethyl sulphoxide (DMSO) on cochlear organotypic cultures. Heart Res 2008; 236: 1–2.

    Google Scholar 

  66. Aita K, Irie H, Tanuma Y, Toida S, Okuma Y, Mori S et al. Apoptosis in murine lymphoid organs following intraperitoneal administration of dimethyl sulfoxide (DMSO). Exp Mol Pathol 2005; 79: 265–271.

    CAS  PubMed  Google Scholar 

  67. Pal R, Bhonde R, Mamidi MK, Das AK . Diverse effects of dimethyl sulfoxide (DMSO) on the differentiation potential of human embryonic stem cells. Arch Toxicol 2012; 86: 651–661.

    CAS  PubMed  Google Scholar 

  68. Jasmin, Spray DC, Campos de Carvalho AC, Mendez-Otero R . Chemical induction of cardiac differentiation in P19 embryonal carcinoma stem cells. Stem Cells Dev 2010; 19: 403–411.

    CAS  PubMed  PubMed Central  Google Scholar 

  69. Marks PA, Breslow R . Dimethyl sulfoxide to vorinostat: development of this histone deacetylase inhibitor as an anticancer drug. Nat Biotechnol 2007; 25: 84–90.

    CAS  PubMed  Google Scholar 

  70. Miller D, Allison D, Rorvik M, Slaga T . Inhibited morphological terminal differentiation and enhanced proliferation of cultured mouse epidermal-cells at different concentrations of dimethyl-sulfoxide. Cell Prolif 1991; 24: 191–210.

    CAS  PubMed  Google Scholar 

  71. Lin C, Kalunta C, Chen F, Nguyen T, Kaptein J, Lad P . Dimethyl-sulfoxide suppresses apoptosis in Burkitts-lymphoma cells. Exp Cell Res 1995; 216: 403–410.

    CAS  PubMed  Google Scholar 

  72. Zyuz'kov GN, Gur'yantseva LA, Simanina EV, Zhdanov VV, Dygai AM, Goldberg ED . Effect of dimethylsulfoxide on the functions of mesenchymal and hemopoietic precursors. Bull Exp Biol Med 2007; 143: 535–538.

    CAS  PubMed  Google Scholar 

  73. Hegner B, Weber M, Dragun D, Schulze-Lohoff E . Differential regulation of smooth muscle markers in human bone marrow-derived mesenchymal stem cells. J Hypertens 2005; 23: 1191–1202.

    CAS  PubMed  Google Scholar 

  74. Lin C, Kalunta C, Chen F, Nguyen T, Kaptein J, Lad P . Dimethyl sulfoxide suppresses apoptosis in Burkitt’s lymphoma cells. Exp Cell Res 1995; 216: 403–410.

    CAS  PubMed  Google Scholar 

  75. Ji L, de Pablo J, Palecek S . Cryopreservation of adherent human embryonic stem cells. Biotechnol Bioeng 2004; 88: 299–312.

    CAS  PubMed  Google Scholar 

  76. Gao DY, Liu J, Liu C, McGann LE, Watson PF, Kleinhans FW et al. Prevention of osmotic injury to human spermatozoa during addition and removal of glycerol. Hum Reprod 1995; 10: 1109–1122.

    CAS  PubMed  Google Scholar 

  77. Zhou X, Gao F, Shu Z, Chung J, Heimfeld S, D Gao . Theoretical and experimental analyses of optimal experimental design for determination of hydraulic conductivity of cell membrane. Biopreserv Biobank 2010; 8: 147–152.

    CAS  PubMed  Google Scholar 

  78. Okamoto Y, Takaue Y, Saito S, Shimizu T, Suzue T, Abe T et al. Toxicities associated with cryopreserved and thawed peripheral-blood stem-cell autografts in children with active cancer. Transfusion 1993; 33: 578–581.

    CAS  PubMed  Google Scholar 

  79. Ozdemir E, Akgedik K, Akdogan S, Kansu E . The lollipop with strawberry aroma may be promising in reduction of infusion-related nausea and vomiting during the infusion of cryopreserved peripheral blood stem cells. Biol Blood Marrow Transplant 2008; 14: 1425–1428.

    PubMed  Google Scholar 

  80. Kessinger A, Armitage JO . The evolving role of autologous peripheral stem cell transplantation following high-dose therapy for malignancies. Blood 1991; 77: 211–213.

    CAS  PubMed  Google Scholar 

  81. Hanslick JL, Lau K, Noguchi KK, Olney JW, Zorumski CF, Mennerick S et al. Dimethyl sulfoxide (DMSO) produces widespread apoptosis in the developing central nervous system. Neurobiol Dis 2009; 34: 1–10.

    CAS  PubMed  Google Scholar 

  82. Authier N, Dupuis E, Kwasiborski A, Eschalier A, Coudoré F . Behavioural assessment of dimethylsulfoxide neurotoxicity in rats. Toxicol Lett 2002; 132: 117–121.

    CAS  PubMed  Google Scholar 

  83. Cavaletti G, Oggioni N, Sala F, Pezzoni G, Cavalletti E, Marmiroli P et al. Effect on the peripheral nervous system of systemically administered dimethylsulfoxide in the rat: a neurophysiological and pathological study. Toxicol Lett 2000; 118: 1–2.

    Google Scholar 

  84. Topacoglu H, Karcioglu O, Ozsarac M, Oray D, Niyazi Ozucelik D, Tuncok Y . Massive intracranial hemorrhage associated with the ingestion of dimethyl sulfoxide. Vet Hum Toxicol 2004; 46: 138–140.

    PubMed  Google Scholar 

  85. Chaloupka JC, Huddle DC, Alderman J, Fink S, Hammond R, Vinters HV . A reexamination of the angiotoxicity of superselective injection of DMSO in the swine rete embolization model. Am J Neuroradiol 1999; 20: 401–410.

    CAS  PubMed  PubMed Central  Google Scholar 

  86. Martino M, Morabito F, Messina G, Irrera G, Pucci G, Iacopino P . Fractionated infusions of cryopreserved stem cells may prevent DMSO-induced major cardiac complications in graft recipients. Haematologica 1996; 81: 59–61.

    CAS  PubMed  Google Scholar 

  87. Garaventa A, Porta F, Rondelli R, Dini G, Meloni G, Bonetti F et al. Early deaths in children after BMT. Bone Marrow Transplant 1992; 10: 419–423.

    CAS  PubMed  Google Scholar 

  88. Thome S, Craze J, Mitchell C . Dimethylsulfoxide-induced serum hyperosmolality after cryopreserved stem-cell graft. Lancet 1994; 344: 1431–1432.

    CAS  PubMed  Google Scholar 

  89. Windrum P, Morris TCM, Drake MB, Niederwieser D, Ruutu T . Variation in dimethyl sulfoxide use in stem cell transplantation: a survey of EBMT centres. Bone Marrow Transplant 2005; 36: 601–603.

    CAS  PubMed  Google Scholar 

  90. Perseghin P, Balduzzi A, Bonanomi S, Dassi M, Buscemi F, Longoni D et al. Infusion-related side-effects in children undergoing autologous hematopoietic stem cell transplantation for acute leukemia. Bone Marrow Transplant 2000; 26: 116–118.

    CAS  PubMed  Google Scholar 

  91. Higman M, Port J, Beauchamp N, Chen A . Reversible leukoencephalopathy associated with re-infusion of DMSO preserved stem cells. Bone Marrow Transplant 2000; 26: 797–800.

    CAS  PubMed  Google Scholar 

  92. Beaujean F, Bourhis J, Bayle C, Jouault H, Divine M, Rieux C . Successful cryopreservation of purified autologous CD34+ cells: influence of freezing parameters on cell recovery and engraftment. Bone Marrow Transplant 1998; 22: 1091–1096.

    CAS  PubMed  Google Scholar 

  93. Kurtzberg J, Laughlin M, Graham ML, Smith C, Olson JF, Halperin EC et al. Placental blood as a source of hematopoietic stem cells for transplantation into unrelated recipients. N Engl J Med 1996; 335: 157–166.

    CAS  PubMed  Google Scholar 

  94. Lee S, Kim S, Kim H, Baek EJ, Jin H, Kim J et al. Post-thaw viable CD34+ cell count is a valuable predictor of haematopoietic stem cell engraftment in autologous peripheral blood stem cell transplantation. Vox Sang 2008; 94: 146–152.

    CAS  PubMed  Google Scholar 

  95. Rowley S, Feng Z, Chen L, Holmberg L, Heimfeld S, MacLeod B et al. A randomized phase III clinical trial of autologous blood stem cell transplantation comparing cryopreservation using dimethylsulfoxide vs dimethylsulfoxide with hydroxyethylstarch. Bone Marrow Transplant 2003; 31: 1043–1051.

    CAS  PubMed  Google Scholar 

  96. Halle P, Tournilhac O, Knopinska-Posluszny W, Kanold J, Gembara P, Boiret N et al. Uncontrolled-rate freezing and storage at −80°C, with only 3.5-percent DMSO in cryoprotective solution for 109 autologous peripheral blood progenitor cell transplantations. Transfusion 2001; 41: 667–673.

    CAS  PubMed  Google Scholar 

  97. Hayakawa J, Joyal EG, Gildner JF, Washington KN, Phang OA, Uchida N et al. 5% Dimethyl sulfoxide (DMSO) and pentastarch improves cryopreservation of cord blood cells over 10% DMSO. Transfusion 2010; 50: 2158–2166.

    CAS  PubMed  PubMed Central  Google Scholar 

  98. Fleming Glass KK, Hubel A, Longmire EK . Optimization of a microfluidic device for diffusion-based extraction of DMSO from a cell suspension. Int J Heat Mass Transf 2008; 51: 5749–5757.

    CAS  PubMed  PubMed Central  Google Scholar 

  99. Fleming KK, Longmire EK, Hubel A . Numerical characterization of diffusion-based extraction in cell-laden flow through a microfluidic channel. J Biomech Eng 2007; 129: 703–711.

    CAS  PubMed  Google Scholar 

  100. Ding W, Yu J, Woods E, Heimfeld S, Gao D . Simulation of removing permeable cryoprotective agents from cryopreserved blood with hollow fiber modules. J Membr Sci 2007; 288: 85–93.

    CAS  Google Scholar 

  101. Ding W, Zhou X, Heimfeld S, Reems J, Gao D . A steady-state mass transfer model of removing CPAs from cryopreserved blood with hollow fiber modules. J Biomech Eng 2010; 132: 011002.

    PubMed  Google Scholar 

  102. Zhou X, Liu Z, Shu Z, Ding W, Du P, Chung J et al. A dilution-filtration system for removing cryoprotective agents. J Biomech Eng 2011; 133: 021007.

    PubMed  Google Scholar 

  103. Houzé P, Dal Cortivo L, Anselme M, Bousquet B, Gourmel B . Quantification of residual dimethyl sulfoxide in supernatants of haematopoietic stem cells by capillary zone electrophoresis. J Chromatogr B 1999; 728: 75–83.

    Google Scholar 

  104. Chen H, Zhou X, Shu Z, Woods EJ, Gao D . Electrical conductivity measurements for the ternary systems of glycerol/sodium chloride/water and ethylene glycol/sodium chloride/water and their applications in cryopreservation. Biopreserv Biobank 2009; 7: 13–17.

    CAS  PubMed  Google Scholar 

  105. Sum A, Faller R, de Pablo J . Molecular simulation study of phospholipid bilayers and insights of the interactions with disaccharides. Biophys J 2003; 85: 2830–2844.

    CAS  PubMed  PubMed Central  Google Scholar 

  106. Crowe J, Crowe L, Oliver A, Tsvetkova N, Wolkers W, Tablin F . The trehalose myth revisited: introduction to a symposium on stabilization of cells in the dry state. Cryobiology 2001; 43: 89–105.

    CAS  PubMed  Google Scholar 

  107. Crowe J, Crowe L . Preservation of mammalian cells—learning nature’s tricks. Nat Biotechnol 2000; 18: 145–146.

    CAS  PubMed  Google Scholar 

  108. Essayan DM, Schilder R, Kagey-Sobotka A, Jenkens MK, Korzeniowski O, Lichtenstein LM et al. Anaphylaxis during autologous peripheral blood progenitor cell infusion. Bone Marrow Transplant 1997; 19: 749–752.

    CAS  PubMed  Google Scholar 

  109. Zager RA . Acute renal failure in the setting of bone marrow transplantation. Kidney Int 1994; 46: 1443–1458.

    CAS  PubMed  Google Scholar 

  110. Marcacci G, Corazzelli G, Becchimanzi C, Arcamone M, Capobianco G, Russo F et al. DMSO-associated encephalopathy during autologous peripheral stem cell infusion: A predisposing role of preconditioning exposure to CNS-penetrating agents? Bone Marrow Transplant 2009; 44: 133–135.

    CAS  PubMed  Google Scholar 

  111. Hazar V, Gungor O, Guven AG, Aydin F, Akbas H, Gungor F et al. Renal function after hematopoietic stem cell transplantation in children. Pediatr Blood Cancer 2009; 53: 197–202.

    PubMed  Google Scholar 

  112. Frisk P, Bratteby LE, Carlson K, Lönnerholm G . Renal function after autologous bone marrow transplantation in children: a long-term prospective study. Bone Marrow Transplant 2002; 29: 129–136.

    CAS  PubMed  Google Scholar 

  113. Keung YK, Lau S, Elkayam U, Chen SC, Douer D . Cardiac-arrhythmia after infusion of cryopreserved stem-cells. Bone Marrow Transplant 1994; 14: 363–367.

    CAS  PubMed  Google Scholar 

  114. Dhodapkar M, Goldberg S, Tefferi A, Gertz M . Reversible encephalopathy after cryopreserved peripheral-blood stem-cell infusion. Am J Hematol 1994; 45: 187–188.

    CAS  PubMed  Google Scholar 

  115. Yellowlees P, Greenfield C, McIntyre N . Dimethylsulfoxide-induced toxicity. Lancet 1980; 2: 1004–1006.

    CAS  PubMed  Google Scholar 

  116. Graves V, Danielson C, Abonour R, McCarthy L . How to ensure safe and well-tolerated stem cell infusions. Transfusion 1998; 38: 30S–30S.

    Google Scholar 

  117. Lopez-Jimenez J, Cervero C, Munoz A, Hernandez-Madrid A, Pineda J, Larana J et al. Cardiovascular toxicities related to the infusion of cryopreserved grafts—results of a controlled-study. Bone Marrow Transplant 1994; 13: 789–793.

    CAS  PubMed  Google Scholar 

  118. Richter E, Eichler H, Raske D, Leveringhaus A, Zieger W, Kerowgan M et al. 5% Me2SO is sufficient to preserve stem cells derived from cord blood. Bone Marrow Transplant 1998; 22 ((Suppl 1)): S16.

    PubMed  Google Scholar 

  119. Abrahamsen JF, Bakken AM, Bruserud Ø . Cryopreserving human peripheral blood progenitor cells with 5-percent rather than 10-percent DMSO results in less apoptosis and necrosis in CD34+ cells. Transfusion 2002; 42: 1573–1580.

    CAS  PubMed  Google Scholar 

  120. Galmés A, Besalduch J, Bargay J, Novo A, Morey M, Guerra JM et al. Long-term storage at −80 degrees C of hematopoietic progenitor cells with 5-percent dimethyl sulfoxide as the sole cryoprotectant. Transfusion 1999; 39: 70–73.

    PubMed  Google Scholar 

  121. Donaldson C, Armitage WJ, Denning-Kendall PA, Nicol AJ, Bradley BA, Hows JM . Optimal cryopreservation of human umbilical cord blood. Bone Marrow Transplantation 1996; 18: 725–731.

    CAS  PubMed  Google Scholar 

  122. Shpall E, LeMaistre C, Holland K, Ball E, Jones R, Saral R et al. A prospective randomized trial of buffy coat versus CD34-selected autologous bone marrow support in high-risk breast cancer patients receiving high-dose chemotherapy. Blood 1997; 90: 4313–4320.

    CAS  PubMed  Google Scholar 

  123. Beaujean F, Hartmann O, Kuentz M, Leforestier C, Divine M, Duedari N . A simple, efficient washing procedure for cryopreserved human hematopoietic stem-cells prior to reinfusion. Bone Marrow Transplant 1991; 8: 291–294.

    CAS  PubMed  Google Scholar 

Download references

Acknowledgements

This study is supported, in part, by funding from NCI (CA18029) and NIDDK (DK56465) to SH, and a pilot grant from NIH to DG.

Author information

Authors and Affiliations

  1. Department of Mechanical Engineering and Department of Bioengineering, University of Washington, Seattle, WA, USA

    Z Shu & D Gao

  2. Division of Clinical Research, Fred Hutchinson Cancer Research Center, Seattle, WA, USA

    S Heimfeld

Authors
  1. Z Shu
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. S Heimfeld
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. D Gao
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding authors

Correspondence to S Heimfeld or D Gao.

Ethics declarations

Competing interests

The authors declare no conflict of interest.

Rights and permissions

Reprints and permissions

About this article

Cite this article

Shu, Z., Heimfeld, S. & Gao, D. Hematopoietic SCT with cryopreserved grafts: adverse reactions after transplantation and cryoprotectant removal before infusion. Bone Marrow Transplant 49, 469–476 (2014). https://doi.org/10.1038/bmt.2013.152

Download citation

  • Received:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1038/bmt.2013.152

Keywords

This article is cited by

Search

Advanced search

Quick links